/Tech1d ago

Life Biosciences doses first patient in Phase 1 trial of ER-100, an epigenetic therapy for age-related vision loss

The therapy uses OSK transcription factors to reset cellular age

164349012141.2K
Siqi Chen#1537
Original post
Siqi Chen@blader#1537inTech

the good news: you will live forever

the bad news: when they said the "permanent" underclass, they really meant it

8:13 PM · Jun 9, 2026 · 321 Views
Sentiment
Sentiment building, check back later.
Cluster Engagement
Posts from X
Most Activity
Most Activity
No ranked X posts are available for this story yet.